144 related articles for article (PubMed ID: 10510139)
1. Pharmacokinetics of bambuterol during oral administration to asthmatic children.
Ahlström H; Alvero J; Alvero R; Espos R; Fajutrao L; Herrera J; Kjellman B; Kubista J; Leviste C; Meyer P; Oldaeus G; Siricururat A; Vichyanond P; Wettrell G; Wong E; Laxmyr L; Nyberg L; Olsson H; Weibull E; Rosenborg J
Br J Clin Pharmacol; 1999 Sep; 48(3):299-308. PubMed ID: 10510139
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of bambuterol during oral administration of plain tablets and solution to healthy adults.
Rosenborg J; Larsson P; Nyberg L
Br J Clin Pharmacol; 2000 Mar; 49(3):199-206. PubMed ID: 10718774
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of bambuterol in subjects homozygous for the atypical gene for plasma cholinesterase.
Bang U; Nyberg L; Rosenborg J; Viby-Mogensen J
Br J Clin Pharmacol; 1998 May; 45(5):479-84. PubMed ID: 9643621
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of bambuterol in healthy subjects.
Nyberg L; Rosenborg J; Weibull E; Jönsson S; Kennedy BM; Nilsson M
Br J Clin Pharmacol; 1998 May; 45(5):471-8. PubMed ID: 9643620
[TBL] [Abstract][Full Text] [Related]
5. Bambuterol in the treatment of asthma. A placebo-controlled comparison of once-daily morning vs evening administration.
D'Alonzo GE; Smolensky MH; Feldman S; Gnosspelius Y; Karlsson K
Chest; 1995 Feb; 107(2):406-12. PubMed ID: 7842769
[TBL] [Abstract][Full Text] [Related]
6. Comparative study using oral solutions of bambuterol once daily or terbutaline three times daily in 2-5-year-old children with asthma. Bambuterol Multicentre Study Group.
Kuusela AL; Marenk M; Sandahl G; Sanderud J; Nikolajev K; Persson B
Pediatr Pulmonol; 2000 Mar; 29(3):194-201. PubMed ID: 10686040
[TBL] [Abstract][Full Text] [Related]
7. One-year safety study with bambuterol once daily and terbutaline three times daily in 2-12-year-old children with asthma. The Bambuterol Multicentre Study Group.
Zarkovic JP; Marenk M; Valovirta E; Kuusela AL; Sandahl G; Persson B; Olsson H
Pediatr Pulmonol; 2000 Jun; 29(6):424-9. PubMed ID: 10821722
[TBL] [Abstract][Full Text] [Related]
8. Clinical-pharmacokinetic aspects of prolonged effect duration as illustrated by beta2-agonists.
Rosenburg J
Eur J Clin Pharmacol; 2002 Jul; 58(4):S1-21. PubMed ID: 12214578
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of bambuterol, a long-acting bronchodilator pro-drug of terbutaline, in young and elderly patients with asthma.
Sitar DS; Warren CP; Aoki FY
Clin Pharmacol Ther; 1992 Sep; 52(3):297-306. PubMed ID: 1526088
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma.
Fugleholm AM; Ibsen TB; Laxmyr L; Svendsen UG
Eur Respir J; 1993 Nov; 6(10):1474-8. PubMed ID: 8112441
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of bambuterol.
Sitar DS
Clin Pharmacokinet; 1996 Oct; 31(4):246-56. PubMed ID: 8896942
[TBL] [Abstract][Full Text] [Related]
12. Comparison between a new once-daily, bronchodilating drug, bambuterol, and terbutaline sustained-release, twice daily.
Persson G; Gnosspelius Y; Anehus S
Eur Respir J; 1988 Mar; 1(3):223-6. PubMed ID: 3384075
[TBL] [Abstract][Full Text] [Related]
13. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
[TBL] [Abstract][Full Text] [Related]
14. One month treatment with the once daily oral beta 2-agonist bambuterol in asthmatic patients.
Persson G; Baas A; Knight A; Larsen B; Olsson H
Eur Respir J; 1995 Jan; 8(1):34-9. PubMed ID: 7744191
[TBL] [Abstract][Full Text] [Related]
15. Bambuterol: dose response study of a new terbutaline prodrug in asthma.
Holstein-Rathlou NH; Laursen LC; Madsen F; Svendsen UG; Gnosspelius Y; Weeke B
Eur J Clin Pharmacol; 1986; 30(1):7-11. PubMed ID: 3519240
[TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled dose-finding study with bambuterol in elderly patients with asthma.
Sitar DS; Aoki FY; Warren CP; Knight A; Grossman RF; Alexander M; Soliman S
Chest; 1993 Mar; 103(3):771-6. PubMed ID: 8449067
[TBL] [Abstract][Full Text] [Related]
17. [Study on bioequivalence of domestic bambuterol capsules and imported tablets by high performance capillary zone electrophoresis].
Shi AX; Li KX; Sun CH; Cao GY
Yao Xue Xue Bao; 2003 Dec; 38(12):942-5. PubMed ID: 15040091
[TBL] [Abstract][Full Text] [Related]
18. Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.
Cazzola M; Calderaro F; Califano C; Di Pema F; Vinciguerra A; Donner CF; Matera MG
Eur J Clin Pharmacol; 1999 Jan; 54(11):829-33. PubMed ID: 10027655
[TBL] [Abstract][Full Text] [Related]
19. Comparison of oral bambuterol and terbutaline in elderly patients with chronic reversible airflow obstruction.
McDonald CF; Pierce RJ; Thompson PJ; Allen D; Bowler S; Breslin AB; Bowes G; Saunders N; Murree-Allen K; Frith P; Musk AW
J Asthma; 1997; 34(1):53-9. PubMed ID: 9033440
[TBL] [Abstract][Full Text] [Related]
20. Bambuterol: effective in nocturnal asthma.
Petrie GR; Chookang JY; Hassan WU; Morrison JF; O'Reilly JF; Pearson SB; Shneerson JM; Tang OT; Ning AC; Turbitt ML
Respir Med; 1993 Nov; 87(8):581-5. PubMed ID: 8290741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]